The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 25, 2022
Filed:
Apr. 17, 2020
Applicant:
Olema Pharmaceuticals, Inc., San Francisco, CA (US);
Inventors:
David C. Myles, Berkeley, CA (US);
Peter J. Kushner, San Francisco, CA (US);
Cyrus L. Harmon, Bolinas, CA (US);
Assignee:
Olema Pharmaceuticals, Inc., San Francisco, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/475 (2006.01); A61K 31/4545 (2006.01); A61K 31/506 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/4545 (2013.01); A61K 31/475 (2013.01); A61K 31/506 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07D 471/04 (2013.01);
Abstract
The present disclosure provides tetrahydro-1H-pyrido[3,4-b]indole compounds or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, rotamer, N-oxide and/or substituted derivative or, optionally in a pharmaceutical composition, for the modulation of disorders mediated by estrogen, or other disorders as more fully described herein.